Combination of Balsamin and Flavonoids Induce Apoptotic Effects in Liver and Breast Cancer Cells

Overview

Journal Front Pharmacol

Date 2020 Nov 16

PMID 33192517

Citations 7

Authors

Parminder K Ajji

Ken Walder

Munish Puri

Affiliations

Soon will be listed here.

Abstract

Flavonoids such as naringenin, quercetin, and naringin are known to exhibit anticancer properties. In this study, we examined the effects of these flavonoids on cell viability and apoptotic pathways of cancer cells, either singly or in combination with the type 1 ribosome inactivating protein, Balsamin. Treatment with flavonoids (naringenin, quercetin, and naringin) plus Balsamin for 48 h reduced HepG2 and MCF-7 cell viability, increased the activation of caspase-3 and -8, and induced apoptosis through up-regulation of pro-apoptotic genes and down-regulation of anti-apoptotic genes. Out of the three flavonoids tested, the Balsamin-Naringenin and Balsamin-Quercetin combinations appeared to be most effective compared to the Balsamin-Naringin combination. Balsamin combined with flavonoids also activated endoplasmic reticulum (ER)-stress-mediated apoptosis in breast cancer (MCF-7) cells, which was not activated by Balsamin treatment alone. These experimental results showed that Balsamin combined with flavonoids can reduce HepG2 and MCF-7 cells viability and induce apoptosis, which could be considered as a promising therapeutic approach to sensitize cells to Balsamin treatment, thereby improving its efficacy in breast or liver cancer therapy.

Citing Articles

The Potential Mechanism of Liujunzi Decoction in the Treatment of Breast Cancer based on Network Pharmacology and Molecular Docking Technology.

Sun M, Lv F, Qin C, Du D, Li W, Liu S Curr Pharm Des. 2024; 30(9):702-726.

PMID: 38415453 DOI: 10.2174/0113816128289900240219104854.

Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer.

Madureira M, Concato V, Cruz E, Bitencourt de Morais J, Inoue F, Santos N Antioxidants (Basel). 2023; 12(3).

PMID: 36978836 PMC: 10045673. DOI: 10.3390/antiox12030586.

Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements.

Sethi G, Rath P, Chauhan A, Ranjan A, Choudhary R, Ramniwas S Pharmaceutics. 2023; 15(2).

PMID: 36840034 PMC: 9960374. DOI: 10.3390/pharmaceutics15020712.

Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies.

Alhalmi A, Amin S, Khan Z, Beg S, Al Kamaly O, Saleh A Pharmaceutics. 2022; 14(9).

PMID: 36145519 PMC: 9500671. DOI: 10.3390/pharmaceutics14091771.

Prevention of Anthracycline-Induced Cardiotoxicity: The Good and Bad of Current and Alternative Therapies.

Sangweni N, van Vuuren D, Mabasa L, Gabuza K, Huisamen B, Naidoo S Front Cardiovasc Med. 2022; 9:907266.

PMID: 35811736 PMC: 9257015. DOI: 10.3389/fcvm.2022.907266.

References

Salehi B, Tsouh Fokou P, Sharifi-Rad M, Zucca P, Pezzani R, Martins N . The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Pharmaceuticals (Basel). 2019; 12(1). PMC: 6469163. DOI: 10.3390/ph12010011. View

Harmon A, Patel Y . Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat. 2004; 85(2):103-10. DOI: 10.1023/B:BREA.0000025397.56192.e2. View

Kaur I, Puri M, Ahmed Z, Blanchet F, Mangeat B, Piguet V . Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina. PLoS One. 2013; 8(9):e73780. PMC: 3764001. DOI: 10.1371/journal.pone.0073780. View

Liu K, Yen C, Wu R, Yang J, Lu H, Lu K . The roles of endoplasmic reticulum stress and mitochondrial apoptotic signaling pathway in quercetin-mediated cell death of human prostate cancer PC-3 cells. Environ Toxicol. 2012; 29(4):428-39. DOI: 10.1002/tox.21769. View

Felgines C, Texier O, Morand C, Manach C, Scalbert A, Regerat F . Bioavailability of the flavanone naringenin and its glycosides in rats. Am J Physiol Gastrointest Liver Physiol. 2000; 279(6):G1148-54. DOI: 10.1152/ajpgi.2000.279.6.G1148. View

Yang Z, Liu Y, Liao J, Gong C, Sun C, Zhou X . Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling. FEBS J. 2015; 282(6):1111-25. DOI: 10.1111/febs.13206. View

Abaza M, Orabi K, Al-Quattan E, Al-Attiyah R . Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer. Cancer Cell Int. 2015; 15:46. PMC: 4464250. DOI: 10.1186/s12935-015-0194-0. View

Park E, Pezzuto J . Flavonoids in cancer prevention. Anticancer Agents Med Chem. 2012; 12(8):836-51. DOI: 10.2174/187152012802650075. View

Kim H, Moon J, Ahn K, Cho S . Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells. Oxid Med Cell Longev. 2014; 2013:596496. PMC: 3863523. DOI: 10.1155/2013/596496. View

10.

Zhao P, Mao J, Zhang S, Zhou Z, Tan Y, Zhang Y . Quercetin induces HepG2 cell apoptosis by inhibiting fatty acid biosynthesis. Oncol Lett. 2014; 8(2):765-769. PMC: 4081423. DOI: 10.3892/ol.2014.2159. View

11.

Kim D, Lee S, Lee S, Park K, Kim W, Moon S . Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis. 2008; 29(9):1701-9. DOI: 10.1093/carcin/bgn055. View

12.

Ahamad M, Siddiqui S, Jafri A, Ahmad S, Afzal M, Arshad M . Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One. 2014; 9(10):e110003. PMC: 4199682. DOI: 10.1371/journal.pone.0110003. View

13.

Chan S, Yang N, Huang C, Liao J, Yeh S . Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. PLoS One. 2013; 8(1):e54255. PMC: 3546961. DOI: 10.1371/journal.pone.0054255. View

14.

Lewandowska U, Gorlach S, Owczarek K, Hrabec E, Szewczyk K . Synergistic interactions between anticancer chemotherapeutics and phenolic compounds and anticancer synergy between polyphenols. Postepy Hig Med Dosw (Online). 2014; 68:528-40. DOI: 10.5604/17322693.1102278. View

15.

Sabarinathan D, Mahalakshmi P, Vanisree A . Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats. Chem Biol Interact. 2010; 189(1-2):26-36. DOI: 10.1016/j.cbi.2010.09.028. View

16.

Puri M, Kaur A, Schwarz W, Singh S, Kennedy J . Molecular characterization and enzymatic hydrolysis of naringin extracted from kinnow peel waste. Int J Biol Macromol. 2010; 48(1):58-62. DOI: 10.1016/j.ijbiomac.2010.09.012. View

17.

Elmore S . Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35(4):495-516. PMC: 2117903. DOI: 10.1080/01926230701320337. View

18.

Bharti S, Rani N, Krishnamurthy B, Arya D . Preclinical evidence for the pharmacological actions of naringin: a review. Planta Med. 2014; 80(6):437-51. DOI: 10.1055/s-0034-1368351. View

19.

Johnson G, White M, Grimaldi M . Stressed to death: targeting endoplasmic reticulum stress response induced apoptosis in gliomas. Curr Pharm Des. 2011; 17(3):284-92. PMC: 3280688. DOI: 10.2174/138161211795049660. View

20.

Arul D, Subramanian P . Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res. 2013; 19(4):763-70. DOI: 10.1007/s12253-013-9641-1. View